ALEXANDRA HUBER: Open Payments
NPI 1669178232 · YORBA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 26 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $170 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 11 | $213 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $99 |
| ABBVIE INC. | 3 | $60 |
| Corcept Therapeutics | 2 | $49 |
| Novo Nordisk Inc | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: RECORLEV, ISTURISA, Korlym, LO LOESTRIN FE, Wegovy, Symbravo, UBRELVY, JARDIANCE.
Industry payments across CA — which companies pay providers there.
